| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $823.4M | — | +2.7% |
| Cost of Revenue | $443.6M | — | +8.1% |
| Gross Profit | $379.8M | — | -2.9% |
| R&D Expense | $101.3M | — | +4.3% |
| SG&A Expense | $242.1M | — | +7.4% |
| Operating Income | $10.2M | — | -67.9% |
| Pre-tax Income | $21.9M | — | -12.7% |
| Income Tax | $2.5M | — | -71.3% |
| Net Income | $14.4M | — | -17.2% |
| EPS (Basic) | $0.02 | — | -81.8% |
| EPS (Diluted) | $0.02 | — | -81.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $133.4M | -55.4% | -27.6% |
| Accounts Receivable | $542.7M | -0.4% | +0.9% |
| Inventory | $1.12B | +2.5% | +0.4% |
| Current Assets | $2.10B | -4.9% | -0.4% |
| Total Assets | $6.13B | -1.8% | +3.3% |
| Current Liabilities | $1.36B | +5.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $71.2M | — | +9.5% |
| Capital Expenditures | $24.2M | — | -6.9% |
| Investing Cash Flow | -$39.7M | — | -52.1% |
| Financing Cash Flow | -$204.9M | — | -300.2% |
| Free Cash Flow | $47.0M | — | +20.5% |
| +0.8% |
| Long-term Debt | $1.67B | -10.6% | -20.9% |
| Stockholders' Equity | $2.47B | +0.4% | +34.6% |